One-dose Janssen COVID-19 vaccine approved by the MHRA
The MHRA has granted COVID-19 Vaccine Janssen a Conditional Marketing Authorisation for prevention of COVID-19 caused by SARS-CoV-2 in adults (aged ≥18). The Summary of Product Characteristics and Patient Information Leaflet are now available.
Source:
Medicines and Healthcare products Regulatory Agency
SPS commentary:
This is the fourth COVID-19 vaccine to be authorised by the MHRA and the first to be approved for protection against COVID-19 with a single dose.
There is currently no information on when this vaccine will be available for use.